JEFFREY M COHEN

Allopathic & Osteopathic Physicians|Dermatology NEW HAVEN, CT NPI 1689054397

General Payments — all program years on this page

$14,178.03

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $12,159.61 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $10,376.002
Travel and Lodging $1,150.685
Food and Beverage $538.2710
Education $94.661

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $11,131.6311
GlaxoSmithKline, LLC. $800.001
Regeneron Healthcare Solutions, Inc. $94.661
Amgen Inc. $80.594
ABBVIE INC. $52.731

By program year

Program yearAmountRecords
2019 $57.111
2021 $100.611
2022 $210.705
2023 $1,650.002
2024 $12,159.6118

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103486187 ABBVIE INC. $52.73 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111552158 Amgen Inc. $20.44 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111552160 Amgen Inc. $16.28 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111552162 Amgen Inc. $23.39 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111552164 Amgen Inc. $20.48 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114027908 Regeneron Healthcare Solutions, Inc. $94.66 11/06/2024 Education Undisputed 01/23/2026 View at CMS
1115821488 GlaxoSmithKline, LLC. $800.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137516151 Takeda Pharmaceuticals U.S.A., Inc. $501.06 04/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137516155 Takeda Pharmaceuticals U.S.A., Inc. $249.99 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137516159 Takeda Pharmaceuticals U.S.A., Inc. $185.00 05/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137516163 Takeda Pharmaceuticals U.S.A., Inc. $50.00 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137516167 Takeda Pharmaceuticals U.S.A., Inc. $59.99 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137516171 Takeda Pharmaceuticals U.S.A., Inc. $30.00 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137516175 Takeda Pharmaceuticals U.S.A., Inc. $14.97 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137516179 Takeda Pharmaceuticals U.S.A., Inc. $204.06 05/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137516183 Takeda Pharmaceuticals U.S.A., Inc. $9,576.00 07/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137516187 Takeda Pharmaceuticals U.S.A., Inc. $127.62 07/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137516191 Takeda Pharmaceuticals U.S.A., Inc. $132.94 07/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.